PathAlert: The Next Generation of Rapid Testing. Easy. Compact. Safe.

Infectious disease outbreaks, such as COVID-19, Influenza, and Mpox, have profoundly impacted public health, with over 500 million confirmed COVID-19 cases and 6 million deaths globally as of 2023¹. Meanwhile, Mpox cases surged to over 87,000 reported instances across 110 countries by early 2024².

Given the scale of these outbreaks, Micronbrane Medical introduces a simplified rapid testing method – PathAlert.

As an at-home or Point-of-Care Antigen Rapid Test (ART) kit, PathAlert, is an indispensable tools for managing infectious diseases, providing immediate, cost-effective solutions for:

• Early and Accurate Diagnosis: Essential for reducing transmission by 56% in community settings³.
• Asymptomatic Carrier Screening: Up to 40% of infections may be asymptomatic but still contagious⁴. 
• Outbreak and Epidemic Monitoring: Accelerating response times can lower outbreak duration by 60%⁵.
• Travel and Entry Requirements: Supports containment strategies that enhance global health security
• Treatment Efficacy: Provides actionable data for modifying patient management plans
• Population and Workplace Surveillance: Testing can reducing the potential for larger-scale spread

Shortage and Complexity of Current Tests

The global shortage of rapid detection tests is a significant challenge to controlling infectious disease outbreaks. The shortage is particularly acute in low- and middle-income countries, where resources are limited, and the demand for reliable, quick diagnostics far exceeds supply. 

In addition, the complexity of traditional ARTs, which often involve multiple steps and components, increases the risk of user error and contamination. This is problematic even in well-resourced settings and such errors could reduce test accuracy by up to 30%⁶.

 The scarcity of ARTs, compounded by these reliability issues, undermines global efforts to detect, monitor, and contain infectious diseases effectively. 

A Single-Tube Solution from Micronbrane Medical

PathAlert is designed to simplify testing thus improving diagnostic accuracy. 

Unlike conventional rapid antigen tests with multiple components — such as swabs, buffer solutions, test strips, and tubes — PathAlert’s innovative design consolidates all testing steps into a single tube container, making it easy, compact, and safe.